Cargando…
Histone methyltransferase SETD2 inhibits tumor growth via suppressing CXCL1-mediated activation of cell cycle in lung adenocarcinoma
The histone H3 lysine 36 methyltransferase SET-domain-containing 2 (SETD2) has been reported to be frequently mutated or deleted in many types of human cancer. However, the role of SETD2 in lung adenocarcinoma (LUAD) has not been well documented. In the present study, we found that SETD2 was signifi...
Autores principales: | Zhou, You, Zheng, Xiao, Xu, Bin, Deng, Haifeng, Chen, Lujun, Jiang, Jingting |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7803529/ https://www.ncbi.nlm.nih.gov/pubmed/33223508 http://dx.doi.org/10.18632/aging.104120 |
Ejemplares similares
-
Inhibition of histone methyltransferase SETD8 represses DNA virus replication
por: Chen, Lin, et al.
Publicado: (2022) -
Histone methyltransferase SETD1A participates in lung cancer progression
por: Du, Mei, et al.
Publicado: (2021) -
The histone methyltransferase SETD2 negatively regulates cell size
por: Molenaar, Thom M., et al.
Publicado: (2022) -
Genomic disruption of the histone methyltransferase SETD2 in chronic lymphocytic leukaemia
por: Parker, H, et al.
Publicado: (2016) -
The histone methyltransferase Setd2 is indispensable for V(D)J recombination
por: Ji, Zhongzhong, et al.
Publicado: (2019)